- Home
- MCRB vs NCTY Comparison
MCRB vs NCTY Comparison
Compare MCRB & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MCRB | NCTY |
|---|---|---|
| Founded | 2010 | 1999 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.7M | 84.0M |
| IPO Year | 2015 | 2004 |
Fundamental Metrics
Financial Performance| Metric | MCRB | NCTY |
|---|---|---|
| Price | $7.79 | $5.67 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 50.9K | 34.0K |
| Earning Date | 05-11-2026 | 03-27-2015 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $789,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.56 | $5.00 |
| 52 Week High | $29.98 | $12.51 |
Technical Indicators
Market Signals| Indicator | MCRB | NCTY |
|---|---|---|
| Relative Strength Index (RSI) | 43.53 | 53.17 |
| Support Level | $6.56 | $5.03 |
| Resistance Level | $9.53 | $5.91 |
| Average True Range (ATR) | 0.64 | 0.37 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 48.04 | 65.52 |
Price Performance
Historical ComparisonAbout MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Online game services, out of which Crypto mining business derives maximum revenue.